34 results about "Mother's milk" patented technology

The invention relates to a powder, such as an amino acid and / or protein powder that is optimized for human beings in the respect that its combined amino acid profile reflects the amino acid profile of human mother's milk protein. The invented powder, such as an amino acid and / or protein powder is suitable to be used as a nutrition supplement and relates also to tablets, capsules or pellets comprising said protein mixture, as well as food products comprising said protein mixture.

The invention relates to a liquid artificial milk feed, a production method and a feeding device, and the liquid artificial milk feed is characterized in that the formula comprises the following raw materials by weight percent: 4-6% of soy protein concentrate, 4-7% of beef extract, 1-3% of starch, 9-11% of whey powder, 4-7% of pure milk, 0.4-0.6% of calcium hydrogen phosphate, 0.2-0.4% of calciumcarbonate, 0.1-0.2% of common salt, 0.02-0.04% of compound vitamin, 0.1-0.3% of compound trace element, 0.01-0.03% of colistin, 0.01-0.02% of kitasamycin, 0.04-0.06% of bacillus subtilis and the balance of drinking water. The liquid artificial milk feed has the advantage of retarding a series of inadaptations of piglets in the aspects of emergency and a digestive system caused by direct transition from sow milk to powder material during delectation of the piglets. The product can not only meet the nutritional requirements for physiology, growth and development of the piglets, but also realize the scientific and safe transition from the liquid sow milk to the powder material.

The invention relates to a breast shield unit for use together with a breast pump for expressing human breast milk, comprising a breast shield (2) for receiving a mother's breast (B) and a media separating device (7, 9) for exerting a vacuum in the interior of the breast shield (2). Said breast shield (2) has a receiving area (33) for receiving a nipple of the mother's breast (B). The media separating device (7, 9) has a media separating diaphragm (9) which can be moved to and fro between two positions for the purpose of transmitting the vacuum. The media separating diaphragm (9) is located in the receiving area (33), at least in one of the two aforementioned positions. The breast shield unit according to the invention can be produced extremely compactly, despite integrated media separation, and minimizes the dead volume.

A method and kit for the sequential early introduction to an infant of at least two allergens to decrease the infant's risk for developing allergies, the method involving administering an initial lower, exposure dose of a first allergen for a day or two, followed by administering a higher maintenance dose of the first allergen for several days, followed by administering the maintenance dose of the first allergen and an initial lower, exposure dose of a second allergen for a day or two, followed by administering the higher maintenance dose of the first allergen and a higher maintenance does of the second allergen for several days. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula or to mother's milk. Alternatively, the allergens can already be provided in baby formula, or in other foods such as snack bars, cookies, or gels.

This invention provides compositions of oligosaccharides, their preparation, and their use to facilitate the growth of certain beneficial gut bacteria over other gut bacteria in a mammal in order to prevent gastrointestinal distress associated with a major change in gut microflora, such as that which occurs when an infant is weaned from its mother's milk to alternative food sources, or during the recovery of the gut microbiome after a course of oral antibiotics, hospitalization, therapy such as chemotherapy or radiation treatments, or conditions where a deficiency in dietary fiber is observed. Novel compositions of oligosaccharides, oligosaccharides and bacteria, foods comprising those compositions, and methods of preparation and use of those compositions are described.

The invention relates to a synthetic composition comprising one or more human milk monosaccharides and / or one or more human milk oligosaccharides for use in reducing intestinal permeability, endotoxemia and / or low-grade inflammation in patients with metabolic disorders.

The present invention provides a method for screening human milk for an adulterant, e.g., non-human milk and infant formula, as well as methods of making human milk compositions free of an adulterant, e.g., human milk fortifiers and standardized human milk formulations.

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in and a method for preventing or treating migraine in a human.

Provided is a technique that makes it possible to promote proliferation of probiotics having a low ability to assimilate human milk oligosaccharides (HMOs), in the presence of HMOs. Also provided is a nutritional composition containing bacteria belonging to Bifidobacterium bifidum, one or more types of probiotics having a low ability to assimilate human milk oligosaccharides, and human milk oligosaccharides. The nutritional composition according to the present technology may be suitably used for foods / drinks, medicines, quasi-drugs, feeds, and the like.

The invention relates to a powdered human milk fortifier comprising a protein component typically present in an amount ranging from 6 wt / wt % to 20 wt / wt % of the fortifier powder, and a fat component typically present in an amount of from about 0.1 wt / wt % to 10 wt / wt % of the fortifier powder and a carbohydrate component selected from the group of Lactose and Oligosaccharides present in the in an amount from 50 wt / wt % to 75 wt / wt % of the fortifier powder; a moisture in the powdered milk fortifier in present in quantity of about 1.5 wt / wt % to about 4.5 wt / wt % of the powdered human milk fortifier; nutrients in the powdered milk fortifier selected from the group of Nucleotides, Minerals including but not limited to calcium, phosphorous, IgA, IgM, IgG, Lactoferrin, Nucleotides, Linolenic acid and Growth factors alike.The invention further provides a powdered human milk lipid rich fortifier with a fat component in a quantity ranging from 40 wt / wt % to about 80 wt / wt %, further in where the lipids are derived from human milk and a moisture component in quantity ranging from 1.5 wt / wt % to about 4.5 wt / wt %; and nutrients selected from the group of Nucleotides, Minerals including but not limited to calcium, phosphorous, IgA, IgM, IgG, Lactoferrin, Nucleotides, Linolenic acid and Growth factors alike.The invention presents an energy rich human milk powder with an energy content in a quantity ranging from 70 cal / 100 mL to about 90 cal / 100 mL; a moisture component in a quantity ranging from 1.5 wt / wt % to about 4.5 wt / wt %; and nutrients selected from the group of Nucleotides, Minerals including but not limited to calcium, phosphorous, IgA, IgM, IgG, Lactoferrin, Nucleotides, Linolenic acid and Growth factors alike.Preferably, the freeze dried human milk fortifier is provided in a unit dose container which holds from about in which about 0.5 gm to about 10 gm of said fortifier. The instant invention also relates to a method of providing nutrition to preterm infants by adding a fortifier powder to human milk and administering the fortified human milk to a premature infant. The invention further provides a method of promoting growth of a premature infant by administering fortified human milk to a premature infant.

A method and a composition comprising human milk oligosaccharides for decreasing the production of detrimental proteolytic metabolites such as ammonia and branched chain fatty acids in the intestinal microbiota of humans, which is useful for the treatment of brain-gut disorders like autism, stress, anxiety, and depressive disorders, are disclosed. Methods of treatment of colon cancer and liver damage are also disclosed.

The present invention provides for pressure indication within the vacuum storage container, as well as a way to isolate mother's milk in a container from air. The present invention utilizes sub-atmospheric pressure to reduce, or at least slow down, the oxidation reactions in breastmilk in order to preserve vitamins, lipids, and other important compounds in the milk, and includes means to measure that sub-atmospheric pressure, so as to provide indications to the user that the correct container pressure has been obtained and maintained.

A mixture of human milk oligosaccharides that consists essentially of 3′-O-sialyllactose, a component A which is either 3-O-fucosyllactose or lacto-N-tetraose, a component B which is 3-O-fucosyl-3′-O-sialyllactose when component A is 3-O-fucosyllactose and sialyllacto-N-tetraose a, when component A is lacto-N-tetraose and optionally lactose as a fourth component. The mixtures are made by treating 3′-O-sialyllactose and component A with an α2,3-transsialidase. The mixtures are for use in anti-bacterial and anti-viral compositions, and for promoting the development of Bifidobacterium and Barnesiella.

The present invention relates to human milk fortifiers comprising high protein content and long chain poly-unsaturated fatty acids. Use of such human milk fortifier improves the body adipose tissue distribution by increasing the subcutaneous adipose tissue mass, while at the same time not increasing visceral adipose tissue.

The invention discloses a recipe recommending method, a device, a system, equipment and a medium for a suckling period. The method comprises the steps of receiving a milk detecting result of a milk provider; acquiring a daily required energy index of the milk provider according to a physiological characteristic parameter of the milk provider; and then acquiring a recommended recipe for the milk provider based on a milk detecting result and the daily required energy index. According to the method of the invention, through the milk detecting result and the daily required energy index of the milkprovider, the individualized recommended recipe for aiming at the milk provider is calculated, and the diet structure of the milk provider is effectively improved.

A breast shield unit of a breast pump for expressing human breastmilk comprises a breast shield to be placed onto a mother's breast, a breastmilk collection container for receiving expressed breastmilk, an adapter for connecting the breast shield to the breastmilk collection container and a valve head. A breastmilk channel extends from the breast shield into the breastmilk collection container through the adapter and the valve head. The valve head includes a valve which closes and opens the breastmilk channel during the pumping action, wherein a fill level sensor for measuring a fill level of the breastmilk collection container is arranged in the valve head. The breast shield unit according to the invention facilitates a fill level measurement without a structural change of the breast shield and breastmilk collection container. Moreover, it facilitates data interchange with external information storage and / or information processing units.

A hands-free milk extraction and collection device including a milk collection container and a housing unit. The milk collection container includes an internal cavity having a first section for receiving a nipple region of a woman's breast and having a second section for collecting milk extracted from the woman's breast. The housing unit is configured to latch onto the nipple region of the woman's breast to aid in stimulating milk flow from the breast by creating suction pressure at the nipple region. The housing unit having a shape contoured to a woman's breast and including a center opening for enclosing the milk collection container, wherein the housing unit and the enclosed milk collection container are collectively configured to fit inside a woman's bra for hands-free usage.

A nipple-shield mounted sensor with associated electronic interface and interconnect for measurement and display of milk flow and volume during breastfeeding. The sensor is mounted in the tip of the nipple-shield in order to minimise intrusion between mother and child. The sensor can be mounted transverse or parallel to the milk flow in the channel depending on the selected sensing technology. Thedimensions of the sensor and associated cabling are such that the device does not appear substantially different to a nipple-shield alone, thereby having minimal impact on the feeding session. Microlitre flow levels are measured directly by the sensor in order to relay accurate, real-time information on milk volume back to the feeding mother. The electronics unit amplifies the sensor input and digitally processes the data with software algorithms to determine the fluid volume, and can be directly integrated in the shield or can constitute an external module depending on the nature of the sensing technology integrated in the flow channel.

The invention discloses a method for large-scale production of CMP-sialic acid through coupled fermentation of genetically engineered bacteria and yeast, and belongs to a fermentation engineering technology. According to the method, on the basis of industrial escherichia coli, CMP-sialidase Neu5Ac is heterologously expressed in the escherichia coli, a genetic engineering strain is constructed, any one of the constructed engineering strain and yeast are subjected to mixed fermentation, CMP and sialic acid are taken as substrates to synthesize the CMP-sialic acid, a feasible way is provided for industrial production of the sialylation step of acid breast milk oligosaccharide-sialylated oligosaccharide, the yield is high, the price is low, and the bottleneck problem that a large amount of sialylated oligosaccharide is difficult to synthesize due to the fact that the CMP-sialic acid is high in price is solved. The yield of the CMP-sialic acid can reach 24.5 g / L after the reaction is carried out for 4 hours under the condition of a fermentation tank, so that the method has obvious social benefits and wide market prospects.

A method and kit for the sequential early introduction to an infant of at least two allergens to decrease the infant's risk for developing allergies, the method involving administering an initial lower, exposure dose of a first allergen for a day or two, followed by administering a higher maintenance dose of the first allergen for several days, followed by administering the maintenance dose of the first allergen and an initial lower, exposure dose of a second allergen for a day or two, followed by administering the higher maintenance dose of the first allergen and a higher maintenance does of the second allergen for several days. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula or to mother's milk. Alternatively, the allergens can already be provided in baby formula, or in other foods such as snack bars, cookies, or gels.

The invention relates to the technical field of lactation bras, in particular to an extension buckle device of a lactation bra and the lactation bra. An extension buckle device of a nursing bra comprises a strip and a first convex buckle, the strip is made of an elastic material and used for providing extension length, one end of the strip is used for being fixedly connected with the first convex buckle, and the first convex buckle is used for being detachably connected with a concave buckle of the nursing bra. When a woman in the lactation period wears the lactation bra with the single lactation buckle and needs to use the portable breast pump, the space between the bra and the body can be enlarged only by connecting the extension buckle device with the convex buckle and the concave buckle of the lactation bra, and the space is used for containing the portable breast pump to collect breast milk.

A disease-resistant nutritive milk used as both medicine and food is prepared from composite vitamines, composite trace elements, antibacterial composition, composite nucleotides, composite fatty acid oil, composite hydrolase, and whole milk powder. Its advantages are no hypersensitivity, easy absorption and digestion, high nutritive and health-care value, and low cost.

The invention relates to a method for operating a breast pump unit for expressing human milk and diverse breast cups for use in said method allowing a maximised pumping output and a minimised pumpingduration per sitting. The breast cup comprises an inner chamber (5) for receiving a nipple (W) of the mother's breast and at least one outer chamber (6) which at least partially surrounds the nipple.The inner chamber (5) is pressurised at a constant pressure and the at least one outer chamber (6) at a pulsating pressure.

A breast shield unit of a breast pump for expressing human breastmilk comprises a breast shield to be placed onto a mother's breast, a breastmilk collection container for receiving expressed breastmilk, an adapter for connecting the breast shield to the breastmilk collection container and a valve head. A breastmilk channel extends from the breast shield into the breastmilk collection container through the adapter and the valve head. The valve head includes a valve which closes and opens the breastmilk channel during the pumping action, wherein a fill level sensor for measuring a fill level of the breastmilk collection container is arranged in the valve head. The breast shield unit according to the invention facilitates a fill level measurement without a structural change of the breast shield and breastmilk collection container. Moreover, it facilitates data interchange with external information storage and / or information processing units.

The invention discloses a branched chain fatty acid enriching method, which comprises following steps: preparing fatty acids from grease, adding a solvent and urea according to a certain ratio, carrying out refluxing under stirring, placing the mixture in a low temperature environment to cool the mixture to carry out crystallization for a certain period, performing suction filtration, subjecting the filtrate to rotary evaporation to remove the solvent, adding water to dissolve the solids, extracting branched chain fatty acids by petroleum ether, washing the organic phase by water to remove urea, adding anhydrous sodium sulfate to dry the organic phase, and finally carrying out rotary evaporation to remove the solvent to obtain high content branched chain fatty acids. Urea is used to clathrate branched chain fatty acids, the separation efficiency is high, the product recovery rate is good, long chain fatty acids that do not exist in human milk are smartly removed, and high purity branched chain fatty acids that are highly similar with human milk are obtained.

A mixture of human milk oligosaccharides that consists essentially of 3′-O-sialyllactose, a component A which is either 3-O-fucosyllactose or lacto-N-tetraose, a component B which is 3-O-fucosyl-3′-O-sialyllactose when component A is 3-O-fucosyllactose and sialyllacto-N-tetraose a, when component A is lacto-N-tetraose and optionally lactose as a fourth component. The mixtures are made by treating 3′-O-sialyllactose and component A with an α2,3-transsialidase. The mixtures are for use in anti-bacterial and anti-viral compositions, and for promoting the development of Bifidobacterium and Barnesiella.